Singlomics Biopharmaceuticals
丹序生物
Singlomics Biopharmaceuticals
Biotech/Healthcare
Danxu Biotech is an innovative drug company that applies a single-cell sequencing platform to antibody drug discovery and development, targeting indications in infectious diseases, autoimmune diseases, and oncology. Its two most advanced candidates, DXP-593 and DXP-604, are neutralizing monoclonal…
Latest round: Pre Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.